Back
Corporate News
Transgene Biotek confirms no Non-Convertible Securities issuance for the September quarter
03-Oct-2026, 07:40
Transgene Biotek Limited informed the BSE Limited that the company has not issued any Non-Convertible Securities, rendering Regulation 57(5) of the SEBI (LODR) Regulations, 2015 not applicable for the quarter ended September 30, 2026.
